Biotech Investment Insights
A deep dive into the complexities of biotech investing reveals the importance of understanding historical successes and failures in the field. The timeline for returns is notably longer, often stretching five to seven years, especially in early-stage ventures. Investors must possess a keen awareness of the landscape, including which disease areas have proven challenging, to navigate this evolving industry effectively.In this clip
From this podcast
The Hard Part with Evan McCann
Richard Waines from DCVC Bio
Related Questions